When once is not enough – further evidence of procalcitonin-guided antibiotic stewardship

被引:0
作者
Stephan Harbarth
Werner C Albrich
Beat Müller
机构
[1] Infection Control Program,Department of Internal Medicine
[2] University of Geneva Hospitals and Medical School,Department of Internal Medicine
[3] Kantonsspital Aarau,undefined
来源
Critical Care | / 13卷
关键词
Procalcitonin; Ongoing Controversy; Critical Care Physician; Pharmaceutical Marketing; Antimicrobial Administration;
D O I
暂无
中图分类号
学科分类号
摘要
Every day, critical care physicians around the world face the same challenge of the optimal timing of antimicrobial administration: when to start and when to stop antibiotics. Duration of antibiotic therapy for sepsis is mostly based on expert opinion, but its reduction is arguably the most promising approach to decrease emergence and selection of antibiotic resistance. The study by Hochreiter and colleagues presents another piece of evidence suggesting that procalcitonin may indeed be a valuable diagnostic parameter to guide antibiotic treatment duration, despite the ongoing controversy about the diagnostic accuracy of pro-calcitonin.
引用
收藏
相关论文
共 117 条
[1]  
Hochreiter M(2009)Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial Crit Care 13 R83-S72
[2]  
Kohler T(2007)Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults Clin Infect Dis 44 S27-2598
[3]  
Schweiger AM(2003)Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial JAMA 290 2588-1854
[4]  
Keck FS(2008)Short- versus long-course antibacterial therapy for community-acquired pneumonia: a meta-analysis Drugs 68 1841-2007
[5]  
Bein B(2008)Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care Arch Intern Med 168 2000-607
[6]  
von Spiegel T(2004)Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial Lancet 363 600-93
[7]  
Schroeder S(2006)Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial Am J Respir Crit Care Med 174 84-19
[8]  
Mandell LA(2007)Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy Chest 131 9-505
[9]  
Wunderink RG(2008)Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial Am J Respir Crit Care Med 177 498-577
[10]  
Anzueto A(2007)Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial BMC Health Serv Res 7 102-226